Cergentis
Clara studied Biology and received her Ph.D. from the University of Barcelona analyzing Next Generation Sequencing data to identify variants in familial cancer patients. She started working at LUMC to learn cell culture and genetic engineering techniques (e.g., cloning, CRISPR/Cas9 and site directed mutagenesis), to assess the function of variants found in DNA repair genes.
At Cergentis, Clara is part of the Service Projects Team performing data analysis for our customers.
Cergentis
1 followers
Cergentis' Targeted Locus Amplification (TLA) Technology uniquely enables the targeted complete Next Generation Sequencing of any genomic locus in any genome of interest.